Keystone Symposia

This meeting took place in 2012

For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

Fibrosis: Translation of Basic Research to Human Disease and Novel Therapeutics (D1)

Organizer(s) Paul W. Noble, Shelia M. Violette and Scott L. Friedman
March 30—April 4, 2012
Big Sky Resort • Big Sky, MT USA
Abstract Deadline: Nov 30, 2011
Late Abstract Deadline: Jan 5, 2012
Scholarship Deadline: Nov 30, 2011
Early Registration Deadline: Jan 30, 2012

Sponsored by Bayer USA Foundation, Celgene Corporation, GlaxoSmithKline UK, Hoffmann-La Roche, Inc. and Regulus Therapeutics Inc.

Summary of Meeting:
Fibrosis is a pathological process in which diseased tissue is replaced with excess extracellular matrix ultimately leading to organ scarring and failure, a final common pathway in many forms of chronic disease affecting multiple tissues. Currently, there are minimal and inadequate treatment options for fibrotic disease. There is an urgent need to understand the cellular, molecular and genetic basis of fibrosis in humans and develop animal models that replicate and illuminate this pathological process. There is also a need to identify prognostic markers of disease susceptibility, biomarkers of disease progression and improved technologies to monitor the effectiveness of new therapies. The goal of the Keystone Symposia meeting on Fibrosis: Translation of Basic Research to Human Disease and Novel Therapeutics is to bring together researchers and clinicians in academia and industry to provide an integrated perspective of basic disease mechanisms, and to address the more pragmatic challenges associated with executing clinical trials and refining approaches to accelerate the clinical development of anti-fibrotic drugs.

View Meeting Program


Early Career Investigator Travel Award Recipients

Colin Jamora
University of California, San Diego, USA

National Heart, Lung, and Blood Institute (NHLBI) Scholarship Recipients

Lee A. Borthwick
Newcastle University, UK

Wanchang Cui
University of Maryland, Baltimore, USA

Lisa Dominak
Cleveland Clinic, USA

Janusz Franco-Barraza
Fox Chase Cancer Center, USA

Virginia Hernandez Gea
Hospital Clinic of Barcelona, University of Barcelona, Spain

Jinu Kim
University of Nebraska Medical Center, USA

Thuy T. Le
University of Texas Health Science Center, Houston, USA

Stefania Lenna
Boston University, USA

Marlies Schippers
University of Groningen, Netherlands